R
Roivant Sciences
Developing transformative medicines faster by building technologies and developing talent in creative ways
At a glance
- Founded
- 2014
- Headquarters
- New York City, United States
- Listing
- Public via SPAC 2021
- Sector
- Biotech & Life Sciences
- Power Law
- Decacorn$10B+ valuation tierThoroughbred$100M+ revenue
Latest news
Press, funding announcements and product moves mentioning Roivant Sciences.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later9 investors entered at this stage
- SGSK Group
- QLQVT Financial LP
- NMNovaQuest Capital Management
- RIRTW Investments
- VIViking Global Investors
SoftBank Vision Fund
Founders Fund- DPDexcel Pharma
SoftBank
Source: Dealroom Talent Intelligence.
Alumni founders
Former Roivant Sciences employees who went on to found companies, sorted by Dealroom signal score.
Vivek RamaswamyUnited States
Alex GasnerUnited States
CFClub FeastEst. 2020
Christopher MiaoUnited States
PBProxima BioEst. 2019
Luca NaefUnited States
KTKriya TherapeuticsEst. 2019
Shankar RamaswamyUnited StatesGlobal footprint
team presence
across markets
Patents
47 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Investments and acquisitions
Disclosed deals where Roivant Sciences was the backer or acquirer, 2016–2026. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.
17 deals across Roivant Sciences's capital deployment.
Where the deals concentrate by sector, stage, and decade.
Where Roivant Sciences deploys vs peers
Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.
Roivant Sciences's portfolio, mapped.
Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Roivant Sciences on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Roivant Sciences on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.